Skip to content

Brain effect mechanism of adolescent depression suicide risk prediction and intervention based on fNIRS and multimodal fMRI

Brain effect mechanism of adolescent depression suicide risk prediction and intervention based on fNIRS and multimodal fMRI

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073759
Enrollment
Unknown
Registered
2023-07-20
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression

Interventions

Experimental Group One:Double target
Experimental Group Two:Single target
Control Group:Sham stimulation

Sponsors

The Second People's Hospital of Guizhou
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 20 Years

Inclusion criteria

Inclusion criteria: Patient group: (1)12-20 years old, the Han nationality, right handed; (2) Diagnosed depression according to the ICD-10; (3) Have not received antidepressant treatment within one month, and have no history of electroconvulsive therapy or transcranial magnetic stimulation therapy. (4) HAMD-17 score >= 17; (5) No electronic or metal device implantation (pacemakers, defibrillators, steel plates, etc.) (6) Signed informed consent and be able to comply with the treatment plan. Healthy group: (1) Han Chinese, aged 12-20 years old, right-handed, with a primary school or above education level; (2) HAMD17 score<7 points; (3) HAMA14 score<7 points; (4) No electronic or metal device implantation (pacemaker, defibrillator, etc.).

Exclusion criteria

Exclusion criteria: Patient group: (1) Suffering from other mental disorders, such as mental retardation, schizophrenia, etc; (2) HAMD-17 score 8 points; (3) Suffering from organic brain diseases or severe physical diseases; (4) Have a history of Substance dependence; (5) There are contraindications for fMRI and fNIRS examinations in pregnant women;

Design outcomes

Primary

MeasureTime frame
fNIRS;fMRI;HAMD;Montgomery-Asperger Depression Rating Scale;

Secondary

MeasureTime frame
HAMA;Scale for Suicide Ideation, SSI;Positive and negative affect scale, PANAS;Connor davidson resilience scale, CD-RISC;Self-rating depression cale, SDS;

Countries

China

Contacts

Public ContactShu Yanping

The Second People's Hospital of Guizhou Province

doctor_sue@yeah.net+86 139 8540 2340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026